Brink Therapeutics
My visitor profile
Brink Therapeutics
Description of your activity
- Brink Therapeutics is transforming gene editing with recombinases, enzymes that modify DNA with unmatched precision and safety compared to CRISPR. Using directed evolution, gene mining, and AI, we develop custom tools for targeted genomic integration. Our focus is enabling in vivo CAR-T therapies to make them scalable, safe, and affordable. By addressing key limitations in genetic medicine, Brink aims to expand access to cutting-edge, life-saving treatments.
More information
Social Networks
Emerging company
Jonathan NACCACHE
CEO
Date of your company creation:
- Less than 1 year
Main sector
- Biotechnology - Therapeutics and Diagnostics
Address
- Country : FRANCE
- City : Paris
- Zip Code : 75005
Participation objectives
Partnering objectives
- Out-licensing / collaboration opportunities, Financing / investment opportunities, Network development